الفهرس 
FUNCTIONAL ANATOMY OF THE FEMALE STRESS CONTINENCE CONTROL SYSTEM
Anterior vaginal / supportOnly 14 pages are availabe for public view
 |  | from | 221 |  |  |
| | | from | 221 | | |
Abstract
Stress urinary incontinence is a distressing symptom which
affects women in all aspects e.g. Health, quality of life and sexual
function and according to many authors it affects high percent of
women.
A large number of procedures were described for the
management of this problem ranging from prevention by avoiding
precipitating factors or early management of diseases that
eventually end by stress incontinence e.g. Bronchial asthma or by
enforcing the pelvic floor muscles after delivery e.g. Kegels
exercise after birth or physiotherapy which is used in mild cases
as the primary procedure before or awaiting surgical intervention
but although conservative treatment for stress incontinence might
give temporary relief, definite cure requires surgery.
Based on the concept of midurethral support system and the
integral theory Ulmsten 1990 introduced his theory about the
mechanism of continence, and later he offered a minimally
invasive surgery for treating female stress incontinence, namely
the tension-free vaginal tape (TVT) procedure, Which achieve
continence by placing a vaginal tape underneath the mid-urethra
without tension to reinforce the weakened pubourethral ligament.
TVT achieves dynamic compression of the urethra at stress.
Stress urinary incontinence is a major global health problem.
Minimally invasive suburethral sling procedures have become a
mainstay for the surgical treatment of women with stress urinary
incontinence. The TVT procedure introduced more than 10 years
ago is now considered by many surgeons to be the gold standard
surgery for female SUI.In this study 100 female patients underwent TVT technique
for treatment of SUI and we had success rate 92%. In short period
follow up, although preoperative and postoperative urodynamic
study showed significant changes toward obstruction, no patient
had abnormal flow, pressure or residual volume after the TVT
procedure and mild degree of de novo voiding dysfunction which
did not persist more than three months after operation.